Loading clinical trials...
Loading clinical trials...
A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
Conditions
Interventions
5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
+2 more
Locations
1
United States
Salus Research, Inc.
Fort Wayne, Indiana, United States
Start Date
January 1, 2013
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
March 26, 2015
NCT07396610
NCT03738514
NCT03553290
NCT01587950
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions